<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28459979</article-id>
<article-id pub-id-type="pmc">5886468</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddx168</article-id>
<article-id pub-id-type="publisher-id">ddx168</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Invited Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Ocular congenital cranial dysinnervation disorders (CCDDs): insights into axon growth and guidance</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Whitman</surname>
<given-names>Mary C.</given-names>
</name>
<xref ref-type="aff" rid="ddx168-aff1">1</xref>
<xref ref-type="aff" rid="ddx168-aff2">2</xref>
<xref ref-type="aff" rid="ddx168-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Engle</surname>
<given-names>Elizabeth C.</given-names>
</name>
<xref ref-type="aff" rid="ddx168-aff1">1</xref>
<xref ref-type="aff" rid="ddx168-aff2">2</xref>
<xref ref-type="aff" rid="ddx168-aff3">3</xref>
<xref ref-type="aff" rid="ddx168-aff4">4</xref>
<xref ref-type="aff" rid="ddx168-aff5">5</xref>
<xref ref-type="aff" rid="ddx168-aff6">6</xref>
<xref ref-type="corresp" rid="ddx168-cor1"></xref>
<!--<email>elizabeth.engle@childrens.harvard.edu</email>-->
</contrib>
</contrib-group>
<aff id="ddx168-aff1">
<label>1</label>F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA 02115, USA</aff>
<aff id="ddx168-aff2">
<label>2</label>Department of Ophthalmology, Boston Children's Hospital, Boston, MA 02115, USA</aff>
<aff id="ddx168-aff3">
<label>3</label>Department of Ophthalmology, Harvard Medical School, Boston, MA 02115, USA</aff>
<aff id="ddx168-aff4">
<label>4</label>Department of Neurology, Boston Children's Hospital, Boston, MA 02115, USA</aff>
<aff id="ddx168-aff5">
<label>5</label>Department of Neurology, Harvard Medical School, Boston, MA 02115, USA</aff>
<aff id="ddx168-aff6">
<label>6</label>Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA</aff>
<author-notes>
<corresp id="ddx168-cor1"><label>*</label>To whom correspondence should be addressed at: Boston Children’s Hospital, CLS 14076, 300 Longwood Ave, Boston, MA 02115, USA. Tel: 617 9194030; Fax: 617 7304834; Email: <email>elizabeth.engle@childrens.harvard.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date iso-8601-date="2017-04-28" pub-type="epub">
<day>28</day>
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>26</volume>
<issue>R1</issue>
<issue-title>Special Review Issue: Eye-Related Disorders</issue-title>
<fpage>R37</fpage>
<lpage>R44</lpage>
<history>
<date date-type="received">
<day>10</day>
<month>4</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>26</day>
<month>4</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>4</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri xlink:href="ddx168.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Unraveling the genetics of the paralytic strabismus syndromes known as congenital cranial dysinnervation disorders (CCDDs) is both informing physicians and their patients and broadening our understanding of development of the ocular motor system. Genetic mutations underlying ocular CCDDs alter either motor neuron specification or motor nerve development, and highlight the importance of modulations of cell signaling, cytoskeletal transport, and microtubule dynamics for axon growth and guidance. Here we review recent advances in our understanding of two CCDDs, congenital fibrosis of the extraocular muscles (CFEOM) and Duane retraction syndrome (DRS), and discuss what they have taught us about mechanisms of axon guidance and selective vulnerability. CFEOM presents with congenital ptosis and restricted eye movements, and can be caused by heterozygous missense mutations in the kinesin motor protein <italic>KIF21A</italic> or in the β-tubulin isotypes <italic>TUBB3</italic> or <italic>TUBB2B.</italic> CFEOM-causing mutations in these genes alter protein function and result in axon growth and guidance defects. DRS presents with inability to abduct one or both eyes. It can be caused by decreased function of several transcription factors critical for abducens motor neuron identity, including <italic>MAFB</italic>, or by heterozygous missense mutations in <italic>CHN1</italic>, which encodes α2-chimaerin, a Rac-GAP GTPase that affects cytoskeletal dynamics. Examination of the orbital innervation in mice lacking <italic>Mafb</italic> has established that the stereotypical misinnervation of the lateral rectus by fibers of the oculomotor nerve in DRS is secondary to absence of the abducens nerve. Studies of a <italic>CHN1</italic> mouse model have begun to elucidate mechanisms of selective vulnerability in the nervous system.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">NIH</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>R01EY012498 and P30HD018655</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="8"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>